AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/coms2/summary_0286-12519173_ITM" title="Facts and information about Intravenous vitamin C is selectively toxic to cancer cells.">Intravenous vitamin C is selectively toxic to cancer cells.</a>
Close
Set up an RSS feed that alerts you when new articles from Townsend Letter for Doctors and Patients are available.
Frequently asked questions about RSS feeds
Intravenous vitamin C is selectively toxic to cancer cells.
National Institutes of Health scientists have confirmed the concepts that vitamin C is selectively toxic to cancer cells and that tumor-toxic levels of vitamin C can be attained using intravenous administration. The article, published in the September 12, 2005 issue of the Proceedings of the ...
Related articles from newspapers, magazines, journals, and more
For more facts and information, see all results
- Intravenous vitamin C is selectively toxic to cancer cells.
- Magazine article from: Townsend Letter for Doctors and Patients December 1, 2005 700+ words
...concepts that vitamin C is selectively toxic to cancer cells and that tumor-toxic levels...in sufficient amounts is selectively toxic to tumor cells. The authors...concentrations selectively kill cancer cells: Action as a pro-drug...
- Intravenous Vitamin C Is Selectively Toxic to Tumor Cells.
- Press release article from: PR Newswire September 21, 2005 700+ words
...1995 that vitamin C in sufficient amounts is selectively toxic to tumor cells. The authors concluded that...NIH confirmed the concepts that vitamin C is selectively toxic to cancer cells and that tumor-toxic levels of vitamin C...
- Lentivirus lytic peptide derivatives selectively toxic to airway pathogens.
- Newspaper article from: AIDS Weekly January 19, 2004 700+ words
...agents derived from lentivirus lytic peptides (LLPs) are selectively toxic to respiratory microbial pathogens. According to published...moderately affected CF cell viability." "Overall, eLLPs are selectively toxic to bacteria and may be useful against CF airway infections...
- Phase I study of high-dose IV vitamin C treatment in patients with solid...
- Magazine article from: Townsend Letter: The Examiner of Alternative Medicine Klotter, Jule August 1, 2007 700+ words
...reported that "vitamin C is selectively toxic to cancer cells and that tumor-toxic...s effect was due to cancer cells' lack of an enzyme that...Intravenous vitamin C is selectively toxic to cancer cells. Townsend Letter. January...
- Columbia University Scientists Develop Cancer 'Terminator' Viruses, Eliminating...
- News wire article from: AScribe Health News Service September 20, 2005 700+ words
...against the distant metastatic cancer cells. In the PNAS paper, Dr...replicates and kills breast cancer cells in mice. Human breast tumor...Fisher's laboratory, which is selectively toxic to cancer cells and is now in phase II clinical...
- Research results from University of Western Australia update understanding of...
- Newspaper article from: Chemicals & Chemistry October 31, 2008 700+ words
...researchers concluded: "The complexes are selectively toxic to two highly tumongenic breast cancer cell...N-heterocyclic carbene complexes that are selectively toxic to cancer cells and target protein selenols in preference to...
- Artemisia annua: herbal use vs isolated active.(Phytotherapy Review &...
- Magazine article from: Townsend Letter for Doctors and Patients Bone, Kerry April 1, 2005 700+ words
...This development is based on the finding that cancer cells have a much higher concentration of iron than...lines have established that artemisinin is also selectively toxic to cancer cells, presumably because their higher iron levels...
- Esperance Pharmaceuticals Closes $9 Million Series A Funding.(Company overview)
- Press release article from: Business Wire October 31, 2006 700+ words
...Tucson, Ariz.). Esperance is developing a unique, targeted, anticancer fusion protein that is selectively toxic to cancer cells. Targeting occurs through the designed ligand component that binds singular extracellular receptors on...
